- cafead Jul 27, 2023 at 10:22: AM
via Biogen, facing declines in sales of older drugs, has a lot riding on its newly approved Alzheimer’s disease treatment.
The company recently announced moves to cut costs and favor investments in innovation and new product launches.
article source
The company recently announced moves to cut costs and favor investments in innovation and new product launches.
article source